BJ Petrof, G Acsadi, A Jani, B Massie, J Bourdon, N Matusiewicz, L Yang, H Lochmuller and G Karpati
Department of Medicine, Royal Victoria Hospital, Montreal, Quebec, Canada.

The protein dystrophin is absent in muscles of patients with Duchenne muscular dystrophy (DMD) as well as in mdx mice. The mdx mouse diaphragm closely resembles the human DMD phenotype and should serve as an appropriate model for future studies of dystrophin gene replacement. In this regard, recombinant adenovirus (AV) holds great promise as a vector for delivering a functional dystrophin gene to muscle. However, the use of AV is hampered by the development of an immune response against transduced cells, resulting in short-lived transgene expression as well as possible adverse effects on organ function. In the present study, sensitive reporter genes were employed to determine the efficiency and functional consequences of AV-mediated gene transfer to the diaphragm in both normal and mdx adult mice. One week after direct intramuscular injection of AV into the diaphragm, the level of transgene expression was significantly increased in mdx compared with normal diaphragms. In addition, small-caliber fibers (< 500 microns2) demonstrated preferential transduction in both groups of mice. Normal diaphragms receiving AV exhibited a substantial reduction in maximal twitch and tetanic force generation, whereas no significant effect on diaphragm contractility was found in the mdx group at 1 wk after injection. At 1 mo after AV administration, however, there was a significant decrease in force production by both normal and mdx diaphragms. Immunosuppression with cyclosporine A over 1 mo did not augment the level of transgene expression, but a beneficial effect on diaphragm force-generating capacity was observed in both groups of animals. We conclude the following: (1) short-term transduction of the diaphragm is more efficient in mdx than in normal mice; (2) AV leads to reduced force production by the diaphragm, with this effect being more pronounced in normal than in mdx in the early (but not the late) postinjection period; and (3) immunosuppressive therapy with cyclosporine has a partially protective effect on muscle function after AV administration, which is apparently unrelated to sparing of transduced fibers from elimination by the host immune system. These findings have important implications for the application of AV-mediated dystrophin gene transfer to the treatment of DMD.

This article has been cited by other articles:

				S. Matecki, R. W. R. Dudley, M. Divangahi, R. Gilbert, J. Nalbantoglu, G. Karpati, and B. J. Petrof Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L569 - L576. [Abstract] [Full Text] [PDF]

				M. Rucker, T. J. Fraites Jr, S. L. Porvasnik, M. A. Lewis, I. Zolotukhin, D. A. Cloutier, and B. J. Byrne Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease Development, June 15, 2004; 131(12): 3007 - 3019. [Abstract] [Full Text] [PDF]

				M.-H. Laprise, F. Grondin, P. Cayer, P. P. McDonald, and C. M. Dubois Furin gene (fur) regulation in differentiating human megakaryoblastic Dami cells: involvement of the proximal GATA recognition motif in the P1 promoter and impact on the maturation of furin substrates Blood, November 15, 2002; 100(10): 3578 - 3587. [Abstract] [Full Text] [PDF]

				J. S. Chamberlain Gene therapy of muscular dystrophy Hum. Mol. Genet., October 1, 2002; 11(20): 2355 - 2362. [Abstract] [Full Text] [PDF]

				C. J. Mann, K. Honeyman, A. J. Cheng, T. Ly, F. Lloyd, S. Fletcher, J. E. Morgan, T. A. Partridge, and S. D. Wilton Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse PNAS, December 14, 2000; (2000) 11408598. [Abstract] [Full Text]

				A. Ahmad, M. Brinson, B.L. Hodges, J.S. Chamberlain, and A. Amalfitano Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy Hum. Mol. Genet., October 1, 2000; 9(17): 2507 - 2515. [Abstract] [Full Text] [PDF]

				S. EBIHARA, G.-H. GUIBINGA, R. GILBERT, J. NALBANTOGLU, B. MASSIE, G. KARPATI, and B. J. PETROF Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice Physiol Genomics, September 8, 2000; 3(3): 133 - 144. [Abstract] [Full Text] [PDF]

				P. ATTAL, F. LAMBERT, S. MARCHAND-ADAM, S. BOBIN, J.-C. POURNY, D. CHEMLA, Y. LECARPENTIER, and C. COIRAULT Severe Mechanical Dysfunction in Pharyngeal Muscle from Adult mdx Mice Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 278 - 281. [Abstract] [Full Text]

				G. Bilbao, J. L. Contreras, H.-G. Zhang, M. J. Pike, K. Overturf, G. Mikheeva, V. Krasnykh, and D. T. Curiel Adenovirus-Mediated Gene Expression In Vivo Is Enhanced by the Antiapoptotic Bcl-2 Gene J. Virol., August 1, 1999; 73(8): 6992 - 7000. [Abstract] [Full Text]

				G.-H. Guibinga, H. Lochmuller, B. Massie, J. Nalbantoglu, G. Karpati, and B. J. Petrof Combinatorial Blockade of Calcineurin and CD28 Signaling Facilitates Primary and Secondary Therapeutic Gene Transfer by Adenovirus Vectors in Dystrophic (mdx) Mouse Muscles J. Virol., June 1, 1998; 72(6): 4601 - 4609. [Abstract] [Full Text] [PDF]

				H.-G. Zhang, G. Bilbao, T. Zhou, J. L. Contreras, J. Gomez-Navarro, M. Feng, I. Saito, J. D. Mountz, and D. T. Curiel Application of a Fas Ligand Encoding a Recombinant Adenovirus Vector for Prolongation of Transgene Expression J. Virol., March 1, 1998; 72(3): 2483 - 2490. [Abstract] [Full Text] [PDF]

				C. J. Mann, K. Honeyman, A. J. Cheng, T. Ly, F. Lloyd, S. Fletcher, J. E. Morgan, T. A. Partridge, and S. D. Wilton Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse PNAS, January 2, 2001; 98(1): 42 - 47. [Abstract] [Full Text] [PDF]